LeadArt Technologies is a venture-backed biotechnology company with a novel and high-throughput chemoproteomic platform. Combing with multiple state-of-art and emerging technologies, LeadArt is a pioneer in expanding the landscape of drug targets, druggable or undruggable.
LeadArt Technologies is aspired to become an engine to generate numerous early drug discovery pipelines, speeding up the drug discovery process and paving the way for more innovative therapeutics that could improve human life.